The Role of the Immune Response in Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is the leading cause of blindness in developed countries; with the aging population, the negative health impacts and costs of the disease will increase dramatically over the next decade. Although the exact cause of AMD is unknown, genetic studies have implicate...

Full description

Bibliographic Details
Main Authors: Scott M. Whitcup, Akrit Sodhi, John P. Atkinson, V. Michael Holers, Debasish Sinha, Bärbel Rohrer, Andrew D. Dick
Format: Article
Language:English
Published: Hindawi Limited 2013-01-01
Series:International Journal of Inflammation
Online Access:http://dx.doi.org/10.1155/2013/348092
id doaj-93640ce106c44ab3a63394598dfd6539
record_format Article
spelling doaj-93640ce106c44ab3a63394598dfd65392020-11-24T22:58:22ZengHindawi LimitedInternational Journal of Inflammation2090-80402042-00992013-01-01201310.1155/2013/348092348092The Role of the Immune Response in Age-Related Macular DegenerationScott M. Whitcup0Akrit Sodhi1John P. Atkinson2V. Michael Holers3Debasish Sinha4Bärbel Rohrer5Andrew D. Dick6Allergan, Inc., 2525 Dupont Drive, Irvine, CA 92612, USAThe Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USADivision of Rheumatology, Washington University School of Medicine, St. Louis, MO 63110, USADivision of Rheumatology, University of Colorado School of Medicine, Aurora, CO 80045, USAThe Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USADepartment of Ophthalmology, Medical University of South Carolina, Charleston, SC 29425, USASchool of Clinical Sciences and School of Cellular and Molecular Medicine, University of Bristol and Bristol Eye Hospital and NIHR, Bristol BS1 2LX, UKAge-related macular degeneration (AMD) is the leading cause of blindness in developed countries; with the aging population, the negative health impacts and costs of the disease will increase dramatically over the next decade. Although the exact cause of AMD is unknown, genetic studies have implicated the complement system as well as other immune responses in disease pathogenesis and severity. Furthermore, histologic studies have shown the presence of macrophages, lymphocytes, and mast cells, as well as fibroblasts, in both atrophic lesions and with retinal neovascularization. This review summarizes discussions from the fifth annual conference of the Arnold and Mabel Beckman Initiative for Macular Research by the Inflammation and Immune Response Task Force. These deliberations focused on the role of inflammatory immune responses, including complement, inflammasomes, adaptive immune responses, and para-inflammation, unanswered questions and studies to address these questions, and potential immune-related therapeutic targets for AMD.http://dx.doi.org/10.1155/2013/348092
collection DOAJ
language English
format Article
sources DOAJ
author Scott M. Whitcup
Akrit Sodhi
John P. Atkinson
V. Michael Holers
Debasish Sinha
Bärbel Rohrer
Andrew D. Dick
spellingShingle Scott M. Whitcup
Akrit Sodhi
John P. Atkinson
V. Michael Holers
Debasish Sinha
Bärbel Rohrer
Andrew D. Dick
The Role of the Immune Response in Age-Related Macular Degeneration
International Journal of Inflammation
author_facet Scott M. Whitcup
Akrit Sodhi
John P. Atkinson
V. Michael Holers
Debasish Sinha
Bärbel Rohrer
Andrew D. Dick
author_sort Scott M. Whitcup
title The Role of the Immune Response in Age-Related Macular Degeneration
title_short The Role of the Immune Response in Age-Related Macular Degeneration
title_full The Role of the Immune Response in Age-Related Macular Degeneration
title_fullStr The Role of the Immune Response in Age-Related Macular Degeneration
title_full_unstemmed The Role of the Immune Response in Age-Related Macular Degeneration
title_sort role of the immune response in age-related macular degeneration
publisher Hindawi Limited
series International Journal of Inflammation
issn 2090-8040
2042-0099
publishDate 2013-01-01
description Age-related macular degeneration (AMD) is the leading cause of blindness in developed countries; with the aging population, the negative health impacts and costs of the disease will increase dramatically over the next decade. Although the exact cause of AMD is unknown, genetic studies have implicated the complement system as well as other immune responses in disease pathogenesis and severity. Furthermore, histologic studies have shown the presence of macrophages, lymphocytes, and mast cells, as well as fibroblasts, in both atrophic lesions and with retinal neovascularization. This review summarizes discussions from the fifth annual conference of the Arnold and Mabel Beckman Initiative for Macular Research by the Inflammation and Immune Response Task Force. These deliberations focused on the role of inflammatory immune responses, including complement, inflammasomes, adaptive immune responses, and para-inflammation, unanswered questions and studies to address these questions, and potential immune-related therapeutic targets for AMD.
url http://dx.doi.org/10.1155/2013/348092
work_keys_str_mv AT scottmwhitcup theroleoftheimmuneresponseinagerelatedmaculardegeneration
AT akritsodhi theroleoftheimmuneresponseinagerelatedmaculardegeneration
AT johnpatkinson theroleoftheimmuneresponseinagerelatedmaculardegeneration
AT vmichaelholers theroleoftheimmuneresponseinagerelatedmaculardegeneration
AT debasishsinha theroleoftheimmuneresponseinagerelatedmaculardegeneration
AT barbelrohrer theroleoftheimmuneresponseinagerelatedmaculardegeneration
AT andrewddick theroleoftheimmuneresponseinagerelatedmaculardegeneration
AT scottmwhitcup roleoftheimmuneresponseinagerelatedmaculardegeneration
AT akritsodhi roleoftheimmuneresponseinagerelatedmaculardegeneration
AT johnpatkinson roleoftheimmuneresponseinagerelatedmaculardegeneration
AT vmichaelholers roleoftheimmuneresponseinagerelatedmaculardegeneration
AT debasishsinha roleoftheimmuneresponseinagerelatedmaculardegeneration
AT barbelrohrer roleoftheimmuneresponseinagerelatedmaculardegeneration
AT andrewddick roleoftheimmuneresponseinagerelatedmaculardegeneration
_version_ 1725647331706011648